9 Biggest Mid-Day Losers For Tuesday

Infinity Pharmaceuticals Inc. INFI shares dipped 70.63 percent to $1.29. Infinity announced plans to cut 21 percent of the workforce. The company also reported that DYNAMO Phase 2 monotherapy study evaluating the efficacy and safety of duvelisib met its primary endpoint.
Mesoblast limited (ADR) MESO shares fell 36.03 percent to $4.52 as the company issued an update on global heart failure program. The company reported that it has regained rights to cardiovascular field for cell therapy platform.
KemPharm Inc KMPH shares fell 26.23 percent to touch a new 52-week low of $4.64 after the company reported that it has received a Complete Response Letter from the FDA regarding its Apadaz NDA .
Dataram Corp DRAM dropped 25.69 percent to $1.07 as the company reached a deal to acquire all of the outstanding shares of US Gold Corp and USGC subsidiaries.
Revance Therapeutics Inc RVNC shares fell 23.02 percent to $14.12 as the company reported that its REALISE 1 Phase 3 trial of DaxibotulinumtoxinA Topical Gel (RT001) to treat patients with moderate to severe lateral canthal lines (crow’s feet) had failed to meet co-primary and other endpoints.
ImmunoGen, Inc. IMGN shares fell 16.87 percent to $4.11 after the company announced a private offering of $100 million in convertible senior notes.
Innocoll Holdings PLC INNL dropped 13.82 percent to $9.48 as the company reported a proposed public offering of $65 million.
Navistar International Corp NAV shares declined 13.69 percent to $11.35. Stifel Nicolaus downgraded Navistar from Hold to Sell.
Western Gas Equity Partners LP WGP shares fell 9.25 percent to $37.88. Western Gas Equity Partners priced 12.5 million common unit offering for gross proceeds of $481 million.